The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections
Finance

EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections

MAR 1, 2024
Women’s Health: The Next Microbiome Frontier
Editor's Choice

Women’s Health: The Next Microbiome Frontier

FEB 20, 2024
Navigating microbiome innovations: Strategic partnerships in Live Biotherapeutic product development
Finance

Navigating microbiome innovations: Strategic partnerships in Live Biotherapeutic product development

FEB 14, 2024
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
Biotics and Supplements

Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation

FEB 8, 2024
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
Finance

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update

FEB 8, 2024
New technology unscrambles the chatter of microbes
Editor's Choice

New technology unscrambles the chatter of microbes

FEB 7, 2024
Researchers discover link between stress and the gut virome
Editor's Choice

Researchers discover link between stress and the gut virome

FEB 5, 2024
Microbiome Drug Development: 2023 in review
Finance

Microbiome Drug Development: 2023 in review

JAN 19, 2024
Smart skin bacteria are able to secrete and produce molecules to treat acne
GMO & Synbio

Smart skin bacteria are able to secrete and produce molecules to treat acne

JAN 11, 2024
AOB Pharma and Maruho enter into an Exclusive License Agreement for Topical Biologic B244
Finance

AOB Pharma and Maruho enter into an Exclusive License Agreement for Topical Biologic B244

JAN 10, 2024
EIB has signed €20 million in venture debt financing with microbiome health company The Akkermansia Company
Finance

EIB has signed €20 million in venture debt financing with microbiome health company The Akkermansia Company

DEC 14, 2023